U.S. Retail Distributors Stock News

If you are wondering whether Block's current share price still offers value, this article will walk through what the numbers say and how that lines up with market expectations. The stock most recently closed at US$59.79, with returns of 11.1% over the last 30 days, a 4.5% gain over the past year, and a 73.4% decline over five years that may still weigh on sentiment. Recent attention on Block has focused on its position in digital payments and financial services, as investors reassess how its...

Essent Group (ESNT) shares are in focus after the mortgage insurer reported flat year on year revenue of US$312.4 million that met expectations, while earnings came in below consensus estimates, shifting attention toward profitability. See our latest analysis for Essent Group. The mixed earnings reaction comes after a softer patch for the share price, with a 30 day share price return of 11.33% and a year to date share price return of a 10.17% decline. Meanwhile, the 1 year total shareholder...

Sesame Workshop has filed a lawsuit against United Parks & Resorts (NYSE:PRKS), alleging unpaid royalties and contractual breaches tied to Sesame Place attractions. The suit seeks to terminate the long running licensing agreement and obtain damages related to the use of the Sesame Street brand in United Parks & Resorts themed entertainment portfolio. The dispute centers on the Sesame Place branded parks, which rely on access to Sesame Workshop intellectual property and characters for their...

A shopper was mistakenly accused of theft by a Five Below employee, and footage of the confrontation has gone viral on social media. The incident has sparked broad discussion about staff training, customer treatment, and store level judgment in discount retail. Five Below, listed as NasdaqGS:FIVE, has not seen this episode prominently reflected in recent coverage that has focused more on valuation and earnings themes. Five Below trades at a share price of $210.36, with the stock up 8.7%...

Varonis Systems (VRNS) stock is drawing attention after recent trading, with investors weighing its US$24.69 last close against a mixed performance over the month and past 3 months in the cybersecurity software space. See our latest analysis for Varonis Systems. Looking beyond the latest move, Varonis Systems has a 90 day share price return of a 25.2% decline and a 1 year total shareholder return of a 38.3% loss, which points to fading momentum after earlier weakness. If this volatility has...

Event context and recent price move Transocean (NYSE:RIG) has recently been on the radar for its sharp total return over the past 3 months, with the stock also showing a mixed pattern across shorter time frames. See our latest analysis for Transocean. At a share price of US$6.36, Transocean’s 90 day share price return of 55.88% and year to date share price return of 50.00% point to building momentum. The 1 year total shareholder return of 109.21% indicates that the recent move fits into a...

Why CorVel is back on investors’ radar Fresh commentary on CorVel (CRVL) is drawing attention to its 85.4% return on invested capital and debt free balance sheet, raising questions about how this quality profile lines up with the current share price. See our latest analysis for CorVel. CorVel’s recent share price tells a mixed story, with a 13.06% 1 month share price return and a 2.21% 1 day gain contrasting with a 24.74% 3 month share price decline and a 50.65% 1 year total shareholder...

Venture Global (NYSE:VG) has closed an $8.6b project financing for phase 2 of its CP2 LNG project. The company has reached a final investment decision for CP2 Phase 2, described as the largest standalone project financing in the U.S. bank market. Nearly all of the project's capacity is contracted to long term customers in Europe and Asia. For investors watching NYSE:VG, the CP2 Phase 2 financing lands at a time when the stock is trading around $13.1. It has shown a sharp move, up 33.9% over...

Costco Wholesale is facing a nationwide class-action lawsuit seeking customer refunds tied to import tariffs. The case follows a Supreme Court decision that struck down certain Trump-era duties, triggering potential government tariff refunds. Plaintiffs argue Costco must pass any tariff-related recoveries back to members who may have overpaid on imported goods. The dispute focuses on Costco's member-first positioning and could influence how large retailers handle future tariff refunds. For...

If you are wondering whether Target's current share price reflects value or whether you would be paying up for a well known brand, this article walks through what the numbers show. Target's stock recently closed at US$117.34, with returns of 2.4% over 30 days, 16.7% year to date and 17.2% over 1 year, while the 3 year and 5 year returns of 18.0% and 27.6% are weaker. Recent coverage has focused on Target's position in U.S. retail, including its big box store footprint, digital sales...

Snap (SNAP) is rolling out “Cricket in a Snap,” an ad offering built around India’s cricket season. It uses AR formats and real-time chat to link brands with Gen Z fans during high-traffic matches. See our latest analysis for Snap. Despite Snap’s push into experiences like “Cricket in a Snap,” recent trading has been weak, with a 7 day share price return of 11.63% and a year to date share price return decline of 43.91%, while the 5 year total shareholder return decline of 92.19% points to...

Mid-America Apartment Communities (MAA) has been drawing attention after recent share price pressure, with the stock showing negative returns over the past month, past 3 months and year. That slump is prompting closer scrutiny from income-focused REIT investors. See our latest analysis for Mid-America Apartment Communities. The latest share price of US$126.32 leaves Mid-America Apartment Communities with a 7-day share price return of a 4.9% decline and a year-to-date share price return of a...

Earlier this month, Vericel Corporation received U.S. FDA approval to begin commercial manufacturing of its MACI cartilage repair therapy at its new Burlington, Massachusetts cell therapy facility starting in the second quarter of 2026, expanding capacity for symptomatic knee cartilage defect treatment in adults. This manufacturing approval not only supports higher MACI production volumes but also strengthens Vericel’s ability to pursue potential commercialization of the therapy in markets...

In February 2026, Affiliated Managers Group reported fourth quarter and full-year 2025 results showing a 22% year-over-year increase in annual economic earnings per share and outlined plans to expand its global private markets presence through new investments in HighBrook Investors and Garda Capital Partners. By deepening partnerships with independent alternative managers, Affiliated Managers Group is reinforcing its position in higher-fee private markets and broadening its exposure to...

Flutter Entertainment’s latest results showed Q4 revenue of US$4.74 billion, up 24.9% year on year but below analyst forecasts for both revenue and earnings per share. On the same day, the company also launched the fifth tranche of its multi‑year share repurchase program, authorizing Goldman Sachs to buy back up to US$250 million of shares to reduce its share count. We’ll now examine how Flutter’s Q4 earnings miss against analyst expectations reshapes the previously optimistic investment...

Halcyon has integrated its technology with Freddie Mac's Asset and Income Modeler (AIM) to support automated dual source income assessment for self employed borrowers. The solution combines borrower provided tax returns with IRS transcripts, automating data validation for lenders using Freddie Mac loans. The capability is immediately available to approved lenders, allowing faster adoption in current mortgage underwriting workflows. For investors watching Federal Home Loan Mortgage...

On 12 March 2026, Fareway Stores announced it had adopted Instacart’s Storefront Pro platform and joined the Instacart Marketplace with no markups on pickup orders, bringing a unified online and app-based grocery shopping experience to its more than 140 Midwestern locations. The partnership showcases Instacart’s enterprise capabilities, such as AI-powered search, integrated fulfillment, and Carrot Ads retail media, which can deepen retailer relationships and broaden higher-margin technology...

If you are wondering whether Cloudflare's share price still makes sense after its strong run, this article will help you unpack what that current price could imply about the company. Cloudflare's stock last closed at US$212.45, with returns of 8.8% over the past week, 12.2% over the past month, 8.4% year to date and 82.9% over the past year. The 3 year and 5 year returns stand at 289.6% and 196.3% respectively. Recent coverage around Cloudflare has continued to focus on its role in content...

Novo Nordisk and Hims & Hers have resolved their legal dispute and entered into a new distribution partnership. Hims & Hers will move patients from compounded GLP-1 products to Novo Nordisk's branded obesity medicines, including Ozempic and Wegovy. As part of the agreement, Hims & Hers will stop promoting compounded GLP-1 alternatives, and Novo Nordisk will withdraw its lawsuit. The deal broadens digital access to Novo Nordisk's FDA approved therapies and tightens control over prescription...

Earlier this month, Hagerty’s Broad Arrow Auctions division set a company and event record at The Amelia Concours, generating over US$111,000,000 in total sales during the 31st running of the classic car celebration. The record auction performance underscores Hagerty’s expanding role in the collector car ecosystem, reinforcing how event-driven services can complement its core insurance and enthusiast offerings. We’ll now examine how Broad Arrow’s record auction sales might influence...

If you are trying to work out whether Ocular Therapeutix at around US$8.76 is a bargain or just fairly priced, starting with a clear view of its valuation can help frame your next move. The stock has seen mixed returns, with a 14.7% decline over the last 7 days and a 4.4% decline over the last 30 days, while the 1 year return sits at 13.5% and the 3 year return at 76.6%, compared with a 57.6% decline over 5 years. Recent market attention on Ocular Therapeutix has focused on its progress as...

Brown-Forman (BF.B) is back in focus after Bernstein cut its rating, citing ongoing margin pressure from higher barrelled whisky costs and softer demand, even though recent quarterly results came in ahead of expectations. See our latest analysis for Brown-Forman. At a share price of $23.49, Brown-Forman has seen momentum fade, with a 30 day share price return of 22.42% and a 90 day share price return of 23.63%. The 5 year total shareholder return of 62.11% highlights how prolonged the...

How BioMarin Pharmaceutical’s Recent Moves Set Up a Closer Look at Value Before we get into the numbers, if you are wondering whether BioMarin Pharmaceutical’s current share price fairly reflects its long term potential, it helps to first step back and see what the market has been doing with the stock lately. BioMarin’s share price closed at US$58.51 most recently, with returns of 4.3% decline over the past week, 3.0% decline over the past month, a 1.6% decline year to date, and a 15.7%...

Investor sentiment toward Concentrix (CNXC) came under pressure as escalating geopolitical tensions triggered a broad risk off move, pulling down business process outsourcing and consulting stocks alongside the wider sector. See our latest analysis for Concentrix. At a recent share price of US$31.67, Concentrix has seen a 7 day share price return of about a 10% decline and a year to date share price return of roughly a 23% decline. The 1 year total shareholder return of around a 28% decline...